The present invention provides a process for the preparation of a compound of the formula (IV):
or salt or ester thereof wherein R1 and R2 are independently hydrogen; an organic radical bonded via a carbon atom to the ring carbon atom; a free, etherified or esterified hydroxy or mercapto group; an amino or acylamino group; or together R1 and R2 represent a group = CR5R6 wherein R5 and R6 are the same or different and each represent hydrogen or a hydrocarbon or heterocyclic group optionally substituted with a functional group; and R3 represents an organic radical; which process comprises reacting a compound of the formula (V):
wherein Rx is hydrogen or a blocking group and R4 is an organic radical; with a thiol or reactive derivative thereof. The compounds of the formula (IV) are useful as antibiotics and [β-lactamase inhibitors, as are the compounds of the formula (V). This invention also provides the novel compounds of the formula (V) and certain novel compounds within formula (IV). Their preparation and use are described.
本发明提供了一种制备式(IV)化合物或其盐或酯的工艺:
或其盐或酯 其中 R1 和 R2 独立地为氢;通过碳原子与环碳原子键合的有机基;游离的、醚化的或酯化的羟基或巯基;
氨基或酰
氨基;或 R1 和 R2 共同代表一个基团=CR5R6 其中 R5 和 R6 相同或不同,且各自代表氢或任选被官能团取代的烃基或杂环基;以及 R3 代表有机基;该工艺包括使式(V):
其中 Rx 是氢或封端基团,R4 是有机基团;与
硫醇或其反应衍
生物反应。式(IV)化合物可用作抗生素和[β-内酰胺酶抑制剂],式(V)化合物也可用作抗生素和[β-内酰胺酶抑制剂]。本发明还提供了新型的式 (V) 化合物和某些新型的式 (IV) 化合物。对它们的制备和用途进行了描述。